Garen Bohlin - May 29, 2024 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/ Nancy Smith, Attorney-in-Fact for Garen Bohlin
Stock symbol
KPTI
Transactions as of
May 29, 2024
Transactions value $
$0
Form type
4
Date filed
5/30/2024, 05:19 PM
Previous filing
May 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Nonstatutory Stock Option (right to buy) Award $0 +69K $0.00 69K May 29, 2024 Common Stock 69K $0.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 100% of the underlying shares on May 29, 2025.